Cardiac Complications of Hypermagnesemia

Introduction to Hypermagnesemia

• Elevated serum magnesium levels can cause significant cardiac complications, including vasodilation, hypotension, bradycardia, cardiac arrhythmias, and in severe cases, cardiorespiratory arrest, according to the American Heart Association 1

Cardiac Effects of Hypermagnesemia

• Progressive cardiac dysfunction occurs when magnesium levels become elevated above normal (>2.2 mEq/L), with effects ranging from minimal cardiac effects at mild levels (2.2-2.5 mEq/L) to severe hypotension, bradycardia, heart blocks, and cardiac arrest at severe levels (>5.0 mEq/L) 1
• The following table summarizes the cardiac effects of hypermagnesemia:

• HyperMagnesemia can be classified into three categories:

  Category	Serum Magnesium Level	Symptoms
  Mild	2.2-2.5 mEq/L	Often asymptomatic or mild symptoms
  Moderate	2.5-5.0 mEq/L	Hyporeflexia, nausea, vomiting, facial flushing, lethargy
  Severe	>5.0 mEq/L	Complete loss of deep tendon reflexes, severe hypotension, respiratory depression, heart blocks, coma

Mechanisms and Risk Factors

• Excessive magnesium impairs cardiac conduction, potentially causing prolonged PR interval, widened QRS complex, heart blocks, and bradycardia, as reported by the American College of Cardiology 1
• Patients with renal insufficiency are at highest risk for developing hypermagnesemia, and regular monitoring of magnesium levels is crucial in these patients, as recommended by the National Kidney Foundation and the American Society of Nephrology 3, 4, 5
• Elderly patients may be more susceptible to magnesium toxicity, and caution should be exercised when prescribing magnesium-containing medications, as suggested by the American Geriatrics Society and the Gerontological Society of America 3, 4, 5
• Obstetric patients receiving magnesium sulfate for preeclampsia/eclampsia need close monitoring of serum magnesium levels to prevent hypermagnesemia, especially if oliguria develops, as recommended by the American College of Obstetricians and Gynecologists 3, 1, 4, 5
• Patients with normal renal function but bowel obstruction taking magnesium-containing medications are at risk of developing severe hypermagnesemia, and alternative medications should be considered, as noted by 2, 6, 5
• Patients with metabolic disorders have a higher susceptibility to toxic effects, as noted by the American Diabetes Association 1

Diagnosis and Monitoring

• Regular assessment of deep tendon reflexes as a clinical marker of magnesium levels is essential in patients with suspected hypermagnesemia, according to the American Academy of Neurology and the American Heart Association 3, 5
• Serial measurements of serum magnesium levels to guide therapy and adjust treatment as needed is crucial in managing hypermagnesemia, as suggested by the National Academy of Clinical Biochemistry and the American Heart Association 3, 5
• Continuous electrocardiographic monitoring is essential for moderate to severe cases, as recommended by the American Heart Association and the American College of Cardiology 3, 6

Treatment and Prevention

• For cardiac complications from hypermagnesemia, immediate intervention with intravenous calcium as a physiological antagonist is recommended, with options including calcium chloride (10%): 5-10 mL (500-1000 mg) IV over 2-5 minutes, or calcium gluconate (10%): 15-30 mL IV over 2-5 minutes 1
• In cases of cardiac arrest suspected to be caused by hypermagnesemia, calcium administration is recommended (Class IIb, LOE C) by the American Heart Association 1, 7
• Administering intravenous calcium as a physiological antagonist is a recommended treatment for severe hypermagnesemia, with a dose of calcium chloride 10% 5-10 mL or calcium gluconate 10% 15-30 mL over 2-5 minutes, as stated by the American Heart Association 2, 1, 5
• Initiate hemodialysis without delay for rapid correction of magnesium levels in patients with severe hypermagnesemia who do not respond to conservative measures, as recommended by the European Renal Association and the National Kidney Foundation 3, 2, 5
• Supportive measures include respiratory support in case of respiratory depression, hemodynamic support in case of hypotension, and hemodialysis in severe cases with inadequate response, as reported by the American College of Cardiology 1
• To prevent hypermagnesemia-induced cardiac problems, it is recommended to avoid magnesium-containing medications in patients with renal insufficiency, verify renal function before administering large amounts of magnesium, and monitor urine output and knee jerk reflexes when administering magnesium, as suggested by medical guidelines 1
• Magnesium-containing laxatives and antacids should be used cautiously in patients with renal impairment, as recommended by the American Society of Nephrology and other guideline societies 3, 2, 1, 5
• The Clinical Nutrition society recommends regular monitoring of magnesium levels in high-risk patients, including those with renal insufficiency, elderly patients, and obstetric patients receiving magnesium sulfate, as well as avoiding magnesium-containing medications in patients with renal insufficiency and verifying renal function before administering large amounts of oral magnesium, as recommended by the American Heart Association, the National Kidney Foundation, and the European Society of Nephrology 3, 2, 4, 5